Related Experiment Video

Updated: Jul 6, 2026

A High-throughput, High-content, Liquid-based C. elegans Pathosystem
09:44

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

Published on: July 1, 2018

Drug discovery: fresh hope to can the worms

Roger K Prichard, Timothy G Geary

    Nature
    |March 14, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans
    08:49

    A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans

    Published on: March 20, 2018

    Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions
    09:54

    Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions

    Published on: July 22, 2022

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    A High-throughput, High-content, Liquid-based C. elegans Pathosystem
    09:44

    A High-throughput, High-content, Liquid-based C. elegans Pathosystem

    Published on: July 1, 2018

    A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans
    08:49

    A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans

    Published on: March 20, 2018

    Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions
    09:54

    Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions

    Published on: July 22, 2022

    Related Concept Videos

    Drug Discovery: Overview01:26

    Drug Discovery: Overview

    Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Flubendazole 2.0: Designing a large field trial in dogs for a challenging setting.

    PLoS neglected tropical diseases·2026

    Current issues in heartworm chemotherapy.

    Parasites & vectors·2026

    Development and evaluation of quadruplex droplet digital PCR assay for rapid detection of molecular markers associated with macrocyclic lactone resistance and susceptibility in Dirofilaria immitis.

    International journal for parasitology. Drugs and drug resistance·2026

    Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data.

    Journal of the American Veterinary Medical Association·2026

    Loiasis: the missing piece in the neglected tropical disease agenda.

    Trends in parasitology·2025

    Brugia malayi miRNAs and potential targets within the feline host (Felis catus).

    Current research in parasitology & vector-borne diseases·2025

    Network-guided Evaluation of β-sitosterol in Inflammatory and Profibrotic Mesangial-Cell Models Relevant to Chronic Glomerulonephritis.

    Journal of visualized experiments : JoVE·2026

    DyAb: sequence-based antibody design and property prediction in a low-data regime.

    mAbs·2026

    A nicotinic-dopaminergic hybrid probe enhances D2-like autoreceptor-mediated inhibition of dopamine release.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

    Chemical biology tools for the O-GlcNAc modification: Determining systems-level functions and druggability.

    Current opinion in chemical biology·2026

    Hybrid design reveals a dopamine D3R ligand with promising in vitro ADME properties.

    Bioorganic chemistry·2026

    The structure of the dopamine D3 receptor bound to cariprazine reveals principles for partial agonists with designed pharmacology.

    Science advances·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us